Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))

Mohamed A. Kamal; Ronald Gieschke; Annabelle Lemenuel-Diot; Catherine A.A. Beauchemin; Patrick F. Smith; Craig R. Raynerd

doi:10.1128/AAC.00179-16

Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))

Mohamed A. Kamal
, Ronald Gieschke
, Annabelle Lemenuel-Diot
, Catherine A.A. Beauchemin
, Patrick F. Smith
, Craig R. Raynerd

Pharmacy

Roche Pharmaceutical Research and Early Development
F. Hoffmann-La Roche AG
Toronto Metropolitan University
Monash University

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1953
Number of pages	1
Journal	Antimicrobial Agents and Chemotherapy
Volume	60
Issue number	3
DOIs	https://doi.org/10.1128/AAC.00179-16
State	Published - Mar 2016

Access to Document

10.1128/AAC.00179-16

Cite this

Kamal, M. A., Gieschke, R., Lemenuel-Diot, A., Beauchemin, C. A. A., Smith, P. F., & Raynerd, C. R. (2016). Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395)). Antimicrobial Agents and Chemotherapy, 60(3), 1953. https://doi.org/10.1128/AAC.00179-16

@article{3b9f4cfc51ff4cc5bd594c20e0db3ddd,

title = "Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))",

author = "Kamal, \{Mohamed A.\} and Ronald Gieschke and Annabelle Lemenuel-Diot and Beauchemin, \{Catherine A.A.\} and Smith, \{Patrick F.\} and Raynerd, \{Craig R.\}",

year = "2016",

month = mar,

doi = "10.1128/AAC.00179-16",

language = "English",

volume = "60",

pages = "1953",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

Kamal, MA, Gieschke, R, Lemenuel-Diot, A, Beauchemin, CAA, Smith, PF & Raynerd, CR 2016, 'Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))', Antimicrobial Agents and Chemotherapy, vol. 60, no. 3, pp. 1953. https://doi.org/10.1128/AAC.00179-16

Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395)). / Kamal, Mohamed A.; Gieschke, Ronald; Lemenuel-Diot, Annabelle et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 60, No. 3, 03.2016, p. 1953.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))

AU - Kamal, Mohamed A.

AU - Gieschke, Ronald

AU - Lemenuel-Diot, Annabelle

AU - Beauchemin, Catherine A.A.

AU - Smith, Patrick F.

AU - Raynerd, Craig R.

PY - 2016/3

Y1 - 2016/3

UR - https://www.scopus.com/pages/publications/84960354695

U2 - 10.1128/AAC.00179-16

DO - 10.1128/AAC.00179-16

M3 - Comment/debate

AN - SCOPUS:84960354695

SN - 0066-4804

VL - 60

SP - 1953

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 3

ER -

Erratum: A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5388-5395))

Access to Document

Other files and links

Fingerprint

Cite this